| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $123K | -96.0% |
| R&D Expense | $12.0M | +6.0% |
| SG&A Expense | $6.2M | -4.5% |
| Operating Income | -$18.1M | -22.8% |
| Net Income | -$18.1M | -22.1% |
| EPS (Basic) | -$0.72 | +11.1% |
| EPS (Diluted) | -$0.72 | +11.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.2M | -82.4% |
| Short-term Investments | $15.9M | — |
| Accounts Receivable | $40K | -63.8% |
| Current Assets | $24.4M | -42.6% |
| Total Assets | $24.9M | -41.3% |
| Current Liabilities | $3.7M | -8.9% |
| Total Liabilities | $3.9M | -3.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.4M | -21.4% |
| Capital Expenditures | $243K | — |
| Investing Cash Flow | -$16.0M | — |
| Financing Cash Flow | -$205K | -100.5% |
| Free Cash Flow | -$17.6M | -23.1% |
| Stockholders' Equity |
| $21.0M |
| -45.2% |